AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Bavarian Nordic

Director's Dealing Sep 5, 2024

3354_rpt_2024-09-05_1fc6359d-a09f-4408-a68b-649fcf92844e.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

Company Announcement

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

COPENHAGEN, Denmark, September 5, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company's shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.

1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Paul John Chaplin
2. Reason for the notification
a) Position/status President and Chief Executive Officer of Bavarian
Nordic A/S
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or
auction monitor
a) Name Bavarian Nordic A/S
b) LEI 2138006JCDVYIN6INP51
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each
type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
a) Description of the financial instrument,
type of instrument
Shares
Identification code DK0015998017
b) Nature of the transaction Exercise of warrants
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 146.60 98,855
d) Aggregated information
-
Aggregated volume
-
Price
98,855
DKK 14,492,143.00
e) Date of the transaction 2024-09-05
f) Place of the transaction Nasdaq Copenhagen A/S, XCSE
1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Henrik Juuel
2. Reason for the notification
a) Position/status Executive Vice President and Chief Financial Officer of
Bavarian Nordic A/S
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or
auction monitor
a) Name Bavarian Nordic A/S
b) LEI 2138006JCDVYIN6INP51
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each
type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted

Page 1 of 2

a) Description of the financial instrument,
type of instrument
Shares
Identification code DK0015998017
b) Nature of the transaction Exercise of warrants
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 146.60 42,916
d) Aggregated information
-
Aggregated volume
-
Price
42,916
DKK 6,291,486.00
e) Date of the transaction 2024-09-05
f) Place of the transaction Nasdaq Copenhagen A/S, XCSE
1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Jean-Christophe May
2. Reason for the notification
a) Position/status Executive Vice President and Chief Commercial Officer
of Bavarian Nordic A/S
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or
auction monitor
a) Name Bavarian Nordic A/S
b) LEI 2138006JCDVYIN6INP51
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each
type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
a) Description of the financial instrument,
type of instrument
Shares
Identification code DK0015998017
b) Nature of the transaction Exercise of warrants
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 155.80 7,039
d) Aggregated information
-
Aggregated volume
-
Price
7,039
DKK 1,096,676.00
e) Date of the transaction 2024-09-05
f) Place of the transaction Nasdaq Copenhagen A/S, XCSE

About Bavarian Nordic

Bavarian Nordic is a fully integrated vaccine company with a mission to protect and save lives through innovative vaccines. We are a global leader in smallpox and mpox vaccines, supplied to governments to enhance public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. For more information visit www.bavarian-nordic.com.

Contacts

Europe: Rolf Sass Sørensen, Vice President Investor Relations, [email protected], Tel: +45 61 77 47 43 US: Graham Morrell, Paddock Circle Advisors, [email protected], Tel: +1 781 686 9600

Company Announcement no. 28 / 2024

Talk to a Data Expert

Have a question? We'll get back to you promptly.